Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

IceCure Medical (ICCM) Profit After Tax (2020 - 2025)

Historic Profit After Tax for IceCure Medical (ICCM) over the last 6 years, with Q3 2025 value amounting to -$17.8 million.

  • IceCure Medical's Profit After Tax fell 133.49% to -$17.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$15.3 million, marking a year-over-year decrease of 1052.48%. This contributed to the annual value of -$15.3 million for FY2024, which is 454.55% down from last year.
  • As of Q3 2025, IceCure Medical's Profit After Tax stood at -$17.8 million, which was down 133.49% from $10.5 million recorded in Q2 2025.
  • In the past 5 years, IceCure Medical's Profit After Tax registered a high of $13.4 million during Q2 2022, and its lowest value of -$22.0 million during Q3 2022.
  • Over the past 5 years, IceCure Medical's median Profit After Tax value was -$3.6 million (recorded in 2024), while the average stood at -$3.6 million.
  • As far as peak fluctuations go, IceCure Medical's Profit After Tax tumbled by 68443.29% in 2021, and later soared by 15709.08% in 2022.
  • Quarter analysis of 5 years shows IceCure Medical's Profit After Tax stood at -$3.2 million in 2021, then fell by 25.06% to -$4.0 million in 2022, then rose by 24.22% to -$3.0 million in 2023, then tumbled by 49.55% to -$4.5 million in 2024, then plummeted by 296.58% to -$17.8 million in 2025.
  • Its Profit After Tax stands at -$17.8 million for Q3 2025, versus $10.5 million for Q2 2025 and -$3.6 million for Q1 2025.